An escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins

mBio

Volumn 4, Issue 3, 2013, Pages

  Maddocks, Oliver David Kenneth ^a,b   Scanlon, Karen Mary ^a   Donnenberg, Michael S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; EFFECTOR PROTEIN; MISMATCH REPAIR PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; ESPFU PROTEIN, E COLI; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; VIRULENCE FACTOR;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; DNA REPAIR; DOWN REGULATION; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; GENE DELETION; GENETIC ASSOCIATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; UPREGULATION; GENETICS; METABOLISM; MISMATCH REPAIR; MITOCHONDRION; MUTATION; MUTATION RATE; PROTEIN TRANSPORT;

ENTEROBACTERIACEAE; ESCHERICHIA COLI;

CARRIER PROTEINS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; MITOCHONDRIA; MUTATION; MUTATION RATE; PROTEIN TRANSPORT; VIRULENCE FACTORS;

EID: 84879590658     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00152-13     Document Type: Article

References (46)

1. Rosenshine I, Ruschkowski S, Stein M, Reinscheid DJ, Mills SD, Finlay BB. 1996. A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates actin pseudopod formation. EMBO J. 15:2613-2624.
2. Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ. 2009. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One 4:e5517. doi: 10.1371/journal.pone.0005517.
3. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. 2004. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127:80-93.
4. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, Lochs H. 1998. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115:281-286.
5. Newman JV, Kosaka T, Sheppard BJ, Fox JG, Schauer DB. 2001. Bacterial infection promotes colon tumorigenesis in Apc(Min/) mice. J. Infect. Dis. 184:227-230.
6. Barthold SW, Jonas AM. 1977. Morphogenesis of early 1,2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res. 37:4352-4360.
7. Jiricny J. 2006. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 7:335-346.
8. Jiricny J. 2000. Mediating mismatch repair. Nat. Genet. 24:6-8
9. Thibodeau SN, Bren G, Schaid D. 1993. Microsatellite instability in cancer of the proximal colon. Science 260:816-819.
10. Sohn KJ, Choi M, Song J, Chan S, Medline A, Gallinger S, Kim YI. 2003. Msh2 deficiency enhances somatic Apc and p53 mutations in Apc/-Msh2-/-mice. Carcinogenesis 24:217-224.
11. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapell A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S. 2004. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96:261-268.
12. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R. 1997. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:808-811.
13. Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J, Papadopolous N, Peltomäki P, de la Chapelle A, Hamilton SR. 1995. Mismatch repair gene defects in sporadic colorectal cancers with micro-satellite instability. Nat. Genet. 9:48-55.
14. Manders P, Spruijt L, Kets CM, Willems HW, Bodmer D, Hebeda KM, Nagtegaal ID, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. 2011. Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome. Eur. J. Cancer 47:1407-1413.
15. Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR. 2000. Steady-state regulation of the human DNA mismatch repair system. J. Biol. Chem. 275:18424-18431.
16. Holmes A, Mühlen S, Roe AJ, Dean P. 2010. The EspF effector, a bacterial pathogen's Swiss army knife. Infect. Immun. 78:4445-4453.
17. Nagai T, Abe A, Sasakawa C. 2005. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J. Biol. Chem. 280:2998-3011.
18. Dean P, Scott JA, Knox AA, Quitard S, Watkins NJ, Kenny B. 2010. The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction. PLoS Pathog. 6:e1000961. doi: 10.1371/journal.ppat.1000961.
19. Nougayrède JP, Donnenberg MS. 2004. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell. Microbiol. 6:1097-1111.
20. Frieden M, James D, Castelbou C, Danckaert A, Martinou JC, Demaurex N. 2004. Ca(2) homeostasis during mitochondrial fragmentation and perinuclear clustering induced by hFis1. J. Biol. Chem. 279: 22704-22714.
21. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. 2009. Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 47: 333-343.
22. Chang CL, Marra G, Chauhan DP, Ha HT, Chang DK, Ricciardiello L, Randolph A, Carethers JM, Boland CR. 2002. Oxidative stress inactivates the human DNA mismatch repair system. Am. J. Physiol. Cell Physiol. 283:C148-C154.
23. Gasche C, Chang CL, Rhees J, Goel A, Boland CR. 2001. Oxidative stress increases frameshift mutations in human colorectal cancer cells. Cancer Res. 61:7444-7448.
24. Cejka P, Marra G, Hemmerle C, Cannavó E, Storchova Z, Jiricny J. 2003. Differential killing of mismatch repair-deficient and -proficient cells: towards the therapy of tumors with microsatellite instability. Cancer Res. 63:8113-8117.
25. Freeman TA, Parvizi J, Della Valle CJ, Steinbeck MJ. 2009. Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty. Fibrogenesis Tissue Repair 2:5. doi: 10.1186/1755-1536-2-5.
26. Ohshima H, Tatemichi M, Sawa T. 2003. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 417: 3-11.
27. Maisonneuve E, Ducret A, Khoueiry P, Lignon S, Longhi S, Talla E, Dukan S. 2009. Rules governing selective protein carbonylation. PLoS One 4:e7269. doi:10.1371/journal.pone.0007269.
28. Kenny B, Jepson M. 2000. Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell. Microbiol. 2:579-590.
29. Hemrajani C, Berger CN, Robinson KS, Marchès O, Mousnier A, Frankel G. 2010. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl. Acad. Sci. U. S. A. 107:3129-3134.
30. Roxas JL, Koutsouris A, Viswanathan VK. 2007. Enteropathogenic Escherichia coli-induced epidermal growth factor receptor activation contributes to physiological alterations in intestinal epithelial cells. Infect. Immun. 75:2316-2324.
31. Lin X, Ramamurthi K, Mishima M, Kondo A, Howell SB. 2000. p53 interacts with the DNA mismatch repair system to modulate the cytotoxicity and mutagenicity of hydrogen peroxide. Mol. Pharmacol. 58: 1222-1229.
32. Beutin L, Marchés O, Bettelheim KA, Gleier K, Zimmermann S, Schmidt H, Oswald E. 2003. HEp-2 cell adherence, actin aggregation, and intimin types of attaching and effacing Escherichia coli strains isolated from healthy infants in Germany and Australia. Infect. Immun. 71: 3995-4002.
33. Pabst WL, Altwegg M, Kind C, Mirjanic S, Hardegger D, Nadal D. 2003. Prevalence of enteroaggregative Escherichia coli among children with and without diarrhea in Switzerland. J. Clin. Microbiol. 41:2289-2293.
34. de la Chapelle A. 2004. Genetic predisposition to colorectal cancer. Nat. Rev. Cancer 4:769-780.
35. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. 2010. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 107:11537-11542.
36. Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, Albertsen H. 2007. APC mutations and other genetic and epigenetic changes in colon cancer. Mol. Cancer Res. 5:165-170.
37. Levine MM, Nataro JP, Karch H, Baldini MM, Kaper JB, Black RE, Clements ML, O'Brien AD. 1985. The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J. Infect. Dis. 152: 550-559.
38. Jarvis KG, Girón JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. U. S. A. 92: 7996-8000.
39. Kenny B, Lai LC, Finlay BB, Donnenberg MS. 1996. EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells. Mol. Microbiol. 20:313-323.
40. Donnenberg MS, Yu J, Kaper JB. 1993. A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J. Bacteriol. 175:4670-4680.
41. McNamara BP, Koutsouris A, O'Connell CB, Nougayréde JP, Donnenberg MS, Hecht G. 2001. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J. Clin. Invest. 107:621-629.
42. Elliott SJ, Krejany EO, Mellies JL, Robins-Browne RM, Sasakawa C, Kaper JB. 2001. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect. Immun. 69:4027-4033.
43. Tu X, Nisan I, Yona C, Hanski E, Rsenshine I. 2003. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol. Microbiol. 47:595-606.
44. Kanack KJ, Crawford JA, Tatsuno I, Karmali MA, Kaper JB. 2005. SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect. Immun. 73: 4327-4337.
45. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520.
46. Tomson FL, Viswanathan VK, Kanack KJ, Kanteti RP, Straub KV, Menet M, Kaper JB, Hecht G. 2005. Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol. Microbiol. 56:447-464.